Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immediate vs Delayed Switch to Carbidopa/Levodopa/Entacapone in PD
NCT00219284Phase 4Completed
- Sponsor
- Novartis
- Start
- Jan 2005
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of entacapone in Parkinson's disease (PD), sponsored by Novartis. Started Jan 2005; status: completed.
02
Drugs
entacapone
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00219284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00219284.